Early phase clinical trial results offer new hope for dyskinesia treatment Date 20 March 2023 An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
Caption A woman working at her computer What the Health and Disability White Paper means for people with Parkinson’s Date 16 March 2023 A brief analysis of what the Health and Disability White Paper means for people with Parkinson's.
What does the 2023 spring budget mean for people with Parkinson’s? Date 15 March 2023 On 15 March, chancellor Jeremy Hunt set out the government’s economic plans. Here’s our summary of the measures announced and their potential impact on people with Parkinson’s and their carers.
Study reveals benefits of physical activity for Parkinson’s symptoms Date 14 March 2023 Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson’s symptoms.
Celebrating the Parkinson’s UK Brain Bank during Brain Awareness Week Date 13 March 2023 Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
Caption People with Parkinson's and a care partner at our round table meeting on growing the Parkinson's workforce Uniting people to discuss increasing the Parkinson’s workforce Date 9 March 2023 Parkinson’s UK brought health leaders, clinicians, people with Parkinson’s and care partners together to discuss key challenges and solutions facing the Parkinson’s healthcare workforce.
Caption Maria and Sally from Reach Your Peak Grant funding helps more people with Parkinson's to get active Date 28 February 2023 Reach Your Peak will use the new physical activity grant funding to subsidise their online fitness and wellbeing sessions for the Parkinson's community.
Co-beneldopa (including Madopar®) change to “special container” status Date 28 February 2023 From 1 February 2023 all Co-beneldopa products, including Madopar, will be provided in pack sizes of 100 only.
Wearable technologies that monitor Parkinson’s symptoms recommended for use by NHS in England Date 15 February 2023 NICE has conditionally recommended 5 remote monitoring devices for Parkinson’s for use in the NHS in England.
We’re celebrating International Day of Women and Girls in Science Date 10 February 2023 This International Day of Women and Girls in Science we’re celebrating some of the pioneering women who are driving Parkinson’s research forward.
